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To investigate the role of secreted metalloproteinases in the 
behavior of skin tumors we have studied immunoreactivity 
for 92-kDa type IV collagenase (92T4Cl) in benign tumors 
of sweat glands, basal cell carcinomas (BCC), baso-squamous 
cell carcinomas (BSCC), and squamous cell carcinomas 
(SeC). In all tumors, the enzyme was fourid in stromal cells, 
but not in tumor epithelium. 92T4CI-positive cells con-
tained the common leukocyte antigen HLe-l (CD4S) and the 
polymorphonuclear leukocyte-specific antigen PMN-8C7. 
Only a few 92T4CI-positive cells expressed either macro-
phage-specific Leu-MS or eosinophil-specific cationic pro-
tein antigens. In benign sweat gland tumors, and in the major-
ity of nodulocystic and adenoid BCCs, 92T4CI-positive cells 
were relatively rare and no extracellular deposition of the 
enzyme was found. In the more aggressive tumors examined, 
T he family of matrix metalloproteinases, including in-terstitial collagenases, type IV collagenases and stro-melysins, plays an important role in extracellular ma-trix (ECM) degradation and remodeling in normal and pathologic processes [1 -8]. A large body of data 
suggests a positive correlation between the expression of metaIlo-
proteinase genes and the metastatic phenotype of malignant cells 
19, 10]. These data mainly concern various in vitro models oftumori-
genesis but very little is known about the relationship between the 
expression of these enzymes in human tumors and their clinical 
behavior. The synthesis of 92-kDa type IV collagenase (92T4Cl) 
has been induced by SV40 transformation of human fibroblasts [7]. 
Under normal circumstances the enzyme is a major secretion prod-
uct of tissue macrophages [7,11] and has been found in the granules 
of polymorphonuclear leukocytes (PMNs) and in cultured keratino-
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Abbreviations: 
BCC: basal cell carcinoma 
BSCC: baso-squamous cell carcinoma 
ECM: extracellular matrix 
HLe-1: common leukocyte antigen 
Leu-M5: monocyte/macrophage specific antigen 
92T4Cl: 92-kDa type IV collagenase 
PBS: phosphate-buffered saline 
PMN-8C7: polymorphonuclear leukocyte specific antigen 
SCC: squamous cell carcinoma 
SGT: sweat gland tumor 
SCCs, BSCC, recurrent, infiltrative, and morpheaform 
BCCs, 92T4CI-positive cells were very abundant. In addi-
tion, a significant quantity of extracellular enzyme was depos-
ited both within the extracellular matrix adjacent to the 
tumor nests and in their basement membrane zone. In normal 
adult skin only a few scattered 92T4CI-containing cells were 
fou?? in the dermis wh~reas in fetal skin, groups of 92T4Cl-
pOSltl.ve, HLe-l- nega~lve cells were present in the upper 
dermIs. These observations suggest that in cutaneous tumors, 
extensive infiltration of 92T4Cl containing polymorphonu-
clear l~ukocytes and the extracellular deposition of the en-
zyme m the basement membrane zone are signs of more 
aggressive tumor behavior.] Invest DermatoI100:159-165, 
1993 
cytes [7]. The pattern of expression of 92T4CI in normal and tumor 
tissues in vivo is unknown. Here we present the results of the immu-
nocytochemicallocalization of this enzyme in human skin tumors 
in comparison with normal fetal and adult human skin. 
Our results demonstrate that in all tumors studied immunoreac-
tivity for 92!4CI was fou?,d only in ECM cells of the surrounding 
connective tissue and not III tumor cells. In addition, infiltration of 
skin tumors with 92T4CI-positive PMNs, accompanied by release 
of the enzyme into the extracellular space, is characteristic for a 
subgroup of skin tumors with a more aggressive behavior. 
MATERIALS AND METHODS 
Thirty-five tumor specimens, including three benign sweat gland 
tumors (SGT), 26 basal cell carcinomas (BCC) (14 were nodulocys-
tic, one keratotic, three adenoid, one superficial, two infiltrative, 
two morphea~orm [desmoplastic], and three recurrent), five squa-
mous cell carclllom.as (SCC), and one baso-squamous cell carcinoma 
(BSCC) wer~ obtallled by surgical excision. Normal skin samples 
[9] were obtallled from healthy volunteers after informed consent, 
and all fetal material originated from spontaneous abortions at ges-
tational ages from 7 to 27 weeks. Specimens were embedded in 
"Tissue-Tek" O. C. T .4583 compound and stored at -70 0 C. Serial 
cryostat sections (5 - 7 jJ. in thickness) were placed on glass slides, 
air-dried, and fixed with 3.5% formaldehyde in Dulbecco's modi-
fied Eagle's phosphate-buffered saline (PBS) for 3.5 min at room 
temperature, washed, and incubated with the following primary 
antibodies: affinity-purified rabbit anti-human 92T4CI (see below), 
mouse monoclonal antibody Leu-M5 (monocyte/macrophage-spe-
cific, CD11c,. Becton, Dickinson), mouse monoclonal antibody 
PMN-8C7 (Sigma), mouse monoclonal antibody HLe-1 (CD45) 
(human leukocyte antigen from the :f200 family, Becton, Dickin-
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son), mouse monoclonal antibody MAS 480 (eosinophil specific, 
Sera Lab), and mouse monoclonal anti-human type IV collagen 
antibody (a kind gift of Dr. Ljubimov, Russian Cancer Research 
Center, Moscow). Two-step indirect immunofluorescence was used 
for all antibodies except anti-92T4CI, for which a biotinylated anti-
rabbit complex was used as the second antibody, followed by incu-
bation with avidin-biotin-fluorescein isothiocyanate - containing 
antibody. Incubation with non-immune rabbit immunoglobulin G 
and/or omission of the primary antibody were used as controls. 
Double immunostaining was performed using a tetramethylrhoda-
mine B isothiocyanate (TRITC) - conjugated anti-mouse antibody 
and double exposures obtained using Nikon filters BA520 for FITC 
and BA590 for Rhodamine B. Hematoxylin-stained slides of all 
tumors were examined by light microscopy and graded. 
Affinity Purification of Anti-92T4CI Antibody 92T4Cl was 
expressed in Escherichia coli, refolded, and purified as described previ-
ously [7,12J. Two milligrams of purified enzyme was dialyzed 
against 0.1 M Borate buffer, pH 8.3, containing 500 mM NaCI and 
attached to a 300-f,ti bed volume of cyanogen bromide-activated 
Sepharose (Sigma) in the same buffer. The slurry was incubated for 
18 h at 4 0 C, and the reaction was terminated according to the 
manufacturer's specifications. Rabbit anti-92T4Cl antiserum, pre-
pared and characterized as we described previously [7], was diluted 
1: 10 with 10 mM Tris-HCl buffer, pH 7.5, and applied on the 
92T4CI-Sepharose column. The column was washed with the same 
buffer containing 500 mM NaCI and antibody was eluted with 
100 mM glycine, pH 2.5, neutralized to pH 7.5, and dialyzed 
against PBS. 
RESULTS 
Immunostaining of 35 human skin tumors with affinity-purified 
anti-92T4Cl specific antibody revealed no detectable enzyme in the 
epithelial cells of any tumor. All 92T4CI-positive cells were found 
within the ECM of the tumors. To identify the source of the en-
zyme-positive cells we used double immunostaining with several 
specific antibodies. Double immunostaining with HLe-l and the 
PMN-specific antibody PMN-8C7 [13,14] showed that 92T4Cl-
positive cells in virtually all cases comprised a subpopulation of cells 
bearing the common leukocyte antigen HLe-1 (Fig la) and the 
PMN-specific antigen (PMN-8C7) (Fig Ib,c) . Approximately 10% 
of 92T4CI-positive cells showed immunoreactivity with monoclo-
nal antibody MAS 480, which is specific for a cationic protein of 
activated eosinophils (Fig Id). Although occasional 92T4CI-posi-
tive cells stained with monocyte/macrophage specific antibody 
Leu-M5, most were Leu-M5 negative. The 92T4CI-positive cells 
were also negative for vimentin and factor VIII antigens, produced 
by fibroblasts and endothelial cells, respectively. 
Although immunostaining for 92T4CI varied among different 
tumor samples, three distinct patterns were identified. The first 
pattern of 92T4Cl staining (type A) is distinct in that only a few 
scattered 92T4CI-positive cells were found in the tumor stroma, 
with some cells in the blood vessels (Fig Ie). No clear morphologic 
features of an inflammatory reaction were visible in this group of 
tumors. This pattern of immunoreactivity was observed in 13 
tumors, including three benign SGTs, five nodulocystic, one kera-
totic, three adenoid, and one superficial BCe. 
The second pattern of 92T4Cl immunostaining (type B) found in 
skin tumors was characterized by numerous 92T4CI-positive cells 
within the inflammatory infiltrate (Fig la,b). The distinct feature of 
this staining pattern is the relatively distant location of the 92T4Cl-
positive cells from the tumor nests and the absence of visible extra-
cellular deposits of the enzyme. Five nodulocystic BCCs of the tu-
mors studied were characterized by this type of enzyme distribution. 
The third pattern (type C) was characterized by widespread areas 
of immunoreactivity for 92T4CI, both intra- and extracellularly. 
Extracellular 92T4Cl was associated with the ECM, the basement 
membrane zone of tumor structures and the adjacent epidermis. 
92T4CI-positive cells were often found in close proximity or di-
rectly adjacent to the tumor nests or even attached to their basement 
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membrane zone (Fig IJ,g) . Seventeen of35 tumors studied exhibited 
this pattern of immunostaining, including 13 of the most aggressive 
tumor types examined, namely, five SCCs, one BSCC, three recur-
rent BCCs, two infiltrative BCCs, and two morpheaform BCCs. 
The most abundant deposition of 92T4Cl was found in the recur-
rent and morpheaform BCCs, BSCC, and SCCs, where all areas of 
connective tissue surrounding tumor structures contained bright 
extracellular staining (Fig 2a,d,g,h,i). Heavy extracellular deposits 
of92T4Cl masked the intracellular location of the enzyme. Double 
immunostaining for 92T4Cl and using HLe-l and PMN-specific 
PMN 8C7 antibodies revealed 92T4CI-positive PMNs in the adja-
cent tumor ECM (Fig 2a,b), confirming that these cells are the 
source of extracellular enzyme. In addition, there was a direct corre-
lation between the immunofluorescent pattern and the cells seen 
in hematoxylin and eosin-stained sections (Fig 2c). A summary 
of the different immunofluorescent staining patterns is presented in 
Table I. 
Four nodulocystic BCCs were found to exhibit a similar but less 
extensive pattern of 92T4Cl immunostaining concentrated close to 
the tumor nests. In these tumors, areas of92T4Cl immunoreactivity 
were seen at the tumor margin (Fig If) extending along the base-
ment membrane of epidermis adjacent to the tumor (Fig Ig). Occa-
sionally, in nodulocystic BCCs a few 92T4CI-positive PMNs were 
found within the tumor nests (not shown). 
The extracellular deposition of the 92T4Cl along the basement 
membrane of the more aggressive tumors examined suggests that 
92T4CI may be involved in the degradation of basement membrane 
components and thus contribute to the invasive behavior of the 
tumors. The precise mechanism(s) remains unclear. Double immu-
nostaining for 92T4CI and type IV collagen did not reveal a discon-
tinuity in the deposition of type IV collagen in the areas of basement 
membrane containing 92T4Cl immunoreactivity. In morphea form 
(desmoplastic) BCCs the basement membrane has been reported to 
be absent or discontinuous [15,16]. Our findings indicate that this 
may not always be the case because we found type IV collagen in the 
basement membrane of morpheaform BCCs to be either intact 
around the tumor nests (Fig 2e) or to be discontinuous (Fig 2j) but in 
no instance was the basement membrane completely absent. Al-
though abundant extracellular deposits of 92T4Cl were frequently 
found adjacent to the tumor cells (Fig 2d) it did not correlate directly 
with the discontinuity of the basement membrane found in these 
tumors. In other aggressive tumors, alterations in the basement 
membrane structure may not be extensive enough to be visualized 
by light microscopy and will require further analysis at the electron 
microscopic level. In addition, local degradation of other ECM 
components is possible in view of the relatively broad spectrum of 
substrate specificity of 92T4Cl in vitro, which includes gelatin, type 
V collagen, fibronectin, and elastin [7,12J. 
Normal Fetal and Adult Human Skin In the vast majority of 
normal adult skin samples, only a few scattered 92T4CI-positive 
cells were found in the dermis. They were around sweat gland ducts 
and adjacent to blood vessels. Some 92T4CI staining cells were also 
seen intravascularly. In two samples (one from the scalp and one 
from the trunk) numerous 92T4CI-positive cells were found only at 
the mid-portion of the hair follicle between the arrector pili muscle 
attachment site and the main sebaceous gland duct, a region analo-
gous to the bulge area described in the mouse pilosebaceous unit [17J 
(Fig 3a) . 92T4CI-positive cells were absent in the dermal papilla 
(anagen stage) and in the connective tissue around the regressed 
epithelial portion of the hair follicle (catagen stage) . Normal adult 
skin contained only occasional 92T4CI-positive cells that were also 
positive for the PMN-specific antigen (using PMN-8C7 antibody) 
similar to those found in the stroma of skin tumors. 
In fetal skin a few 92T4Cl cells appear by the seventh week of 
gestation and are scattered among mesenchymal cells. Between 8 
and 13 weeks of gestation more of these cells become visible, and 
occasional clusters surrounding developing muscle can be seen (Fig 
3b). Starting from the nineteenth week of gestation, groups of 
92T4CI-positive cells were found in the upper layer of the derrnis 
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Figure 1.. Distribution of 92T4Cl-containing cells in basal cell and squamous cell carcinomas. a) Inflammatory infiltrate in a nodulocystic BCC: double 
staining for 92T4Cl (green color) and for the common leukocyte antigen HLe-l (*, and red color). All 92T4Cl-positive cells contain the leukocyte antigen 
( -+ ). Overlap of green and red fluorescence produces the yellow color. Bar, 50 11m. b) Immunolocalization of 92T4CI in PMNs ( -+) in the inflammatory 
infiltrate in the ECM of a nodulocystic BCC. 92T4CI-positive cells are distant from the tumor nest (T). Bar, 60 11m. c) Same section as shown in b stained 
with PMN-BC7 antibody (specific for polymorphonuclear leukocytes) to demonstrate that the majority of 92T4Cl containing cells ( -+ ) are PMNs. (T, 
tumor). Bar, 60 11m. d) Double immunostaining for 92T4Cl (greell color) and for eosinophil specific antigen (red color). Cells containing both antigens (yellow 
color) are present in the tumor stroma of a nodulocystic BCC. 92T4Cl-positive PMNs ( -», 92T4CI negative eosinophils ( > ), 92T4CI containing 
eosinophils (*). T, tumor nest. Bar, 50 11m. e) Double immunostaining for 92T4CI (grew color) and for type IV collagen (red color) in a nodulocystic BCC. 
Note 92T4Cl-positive cells within stromal blood vessels (*). A 92T4Cl-positive PMN can be seen traversing the basement membrane of a blood vessel 
( -+). Bar, 50 11m.}) Double staining with anti-92T4Cl (greell color) and type rv collagen (red color) . In this nodulocystic BCC, 92T4Cl (-» can be seen 
overlying the basement membrane (overlap of green and red fluorescence produces yellow color) surrounding a tumor nest (T). Type IV collagen is 
present in the basement membrane of the blood vessels (*) and surrounding the tumor nests ( > ). Bar, 50 11m. g) Double immunostaining for 92T4Cl 
(green color) and type IV collagen (red color) in an area of the papillary dermis immediately beneath the epidermis (E) directly adjacent to a nodulocystic 
BCC. 92T4Cl-positive cells ( -> ) are outside the blood vessels, which contain type IV collagen in the basement membrane. Extracellular deposits (*) of 
92T4Cl are seen in the ECM. Bar, 50 11m. 
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Figure 2. Patterns of immunofluorescent localization of 92T4Cl in basal cell and squamous cell carcinomas. a) Immunostaining of SCC for 92T4Cl. Both 
extracellular and intracellular 92T4Cl ( -> ) is present in ECM immediately beneath the epidermal portion of the tumor and surrounding the tumor nests 
(T). Bar, 50 11m. b) Same section stained with PMN-8C7 antibody. Immunolocalization confirms that the major source of 92T4Cl is the PMN. T, tumor 
nests; ->, 92T4Cl-positive cells shown in a. Bar, 50 11m. c) Photomicrograph of the same section (see Fig a,b) stained with hematoxylin at a lower 
magnification (bar, 100 11m) using a red filter. This shows the direct correlation between the cells seen in hematoxylin-stained sections and those seen in 
the immunofluorescent photomicrographs. The tumor nests (T) and the 92T4Cl-positive cells (-» are the identical areas shown in a and b. d) 
Morpheaform BCC. Note the extensive extracellular deposition of 92T4Cl (-» adjacent to the tumor nests (t) . Bar, 100 11m. e) Same section stained for 
type IV collagen. No discontinuity in the basement membranes ( -> ) surrounding the tumor nests (t) is noted. Type IV collagen is also present around 
blood vessels (*). Bar, 100 Ilm.J) Morpheaform BCC stained for type IV collagen. This section contains many tumor nests (t) and reveals discontinuity of 
the basement membrane ( -> ). In no instance was the basement membrane completely absent. Small blood vessels are brightly stained (*) . Bar, 50 11m. g) 
Recurrent BCC showing extracellular 92T4Cl immunoreactivity in ECM. Tumor nests (T). Bar, 50 11m. h) SCC showing a heavy extracellular deposition of 
92T4Ci in the ECM adjacent to the tumor nests (T). A linear deposition of 92T4Cl is seen along the basement membrane ( -> ) of the tumor. Bar, 40 11m. I) 
s ec. Note extracellular 92T4Cl adjacent to the tumor in the region of the basement membrane zone. Bar, 40 11m. 
(Fig 3c). In contrast to adult skin, these cells do not stain with the 
specific leukocyte antibodies and appear to represent mesenchymal 
cells. 
DISCUSSION 
Our results demonstrate the accumulation of 92T4Cl in the ECM 
but not in the epithelium of skin tumors. The major source of the 
enzyme in the tumor ECM is infiltrating PMNs, bearing the PMN-
8C7 and HLe-l (CD4S) antigens. A small portion of the 92T4Cl-
positive cells are mature activated eosinophils, bearing the MAS 480 
antigen. A few such cells are of monocyte/macrophage lineage 
positive for the Leu-MS antigen. It has recently been shown by ill 
situ hybridization using 92T4Cl eDNA that, in some skin tumors, 
92T4CI-expressing cells are tissue macrophages [18] and eosino-
phils [19]. Our results clearly demonstrate that these cells represent 
a minor source of the enzyme in the tumor. The majority of 
92T4CI-containing cells are PMNs that are not actively engaged in 
the synthesis of the enzyme at this stage of differentiation as is the 
case with interstitial PMN collagenase [20]. This explains why ill 
situ hybridization does not reveal the major source of the enzyme in 
the tumors under study. 
The findings presented here show that three distinct patterns of 
92T4CI immunostaining are visible in human skin tumors. In the 
first group, only a few scattered 92T4CI-positive cells were found 
in the ECM and in normal adult skin. This was the common pattern 
seen in benign tumors (SGT) and in several nodulocystic and ade-
noid BCCs. 
The second group of tumors (nodulocystic BCCs) was character-
ized by numerous clusters of 92T4CI-positive cells found in the 
inflammatory infiltrate. These were relatively distant from the 
tumor nests and no extracellular deposition of the enzyme was 
found. 
Tumors in the third group contain abundant 92T4CI-positive 
cells in the ECM often close to the tumor basement membrane zone. 
In these tumors there is extensive extracellular deposition of 
92T4Cl in the interstitial matrix and in the tumor basement mem-
brane zone. The most aggressive tumors examined (SCCs, recurrent 
and morpheaform BCCs, BSCC) exhibited a 92T4CI-immuno-
staining pattern characterized by immediate proximity of 92T4Cl-
b.earing leukocytes to tu.mor n~sts and massive extracellular deposi-
tion of the enzyme. Thls findmg suggests that aggressive behavior 
of skin tumors is associated with the migration of 92T4CI-bearing 
PMNs toward the basement membrane zone of the tumor epithe-
lium, and release of the enzyme into the extracellular space from the 
specific granules. ~~e mechanisms that elicit this type of behavior 
from 92T4CI-posltlve leukocytes are not known. Specific che-
moattractants and/or matrix molecules elaborated by tumor cells 
could be responsible for the attraction of92T4CI-containing PMNs 
to the basement membrane. These factors presumably may be re-
sponsible for the release of 92T4Cl from PMN granules. It has 
recently been found .that some s.ynthetic peptides and opsonized 
zymosan are able to mduce speClfic degranulation of metallopro-
teinase-containing granu.les of PMNs in tissue culture [21] . The 
nature of any degranulatmg substances that operate within tumor 
tissue ill vivo remains to be investigated. 
The functional significance of 92T4Cl deposition in ECM struc-
tures, including basem~nt mem.b~ane, is not clear. According to our 
data, in mo~t tumors tlllS deposltion does not appear to lead directly 
to degradatlOn of type IV collagen of tumor, epidermal, or vascular 
Table I. Immunostaining Patterns for 92T4Cl in Skin Tumors 
Total 
Number 
Tumor (type) of Tumors 
SGT" 3 
BCe b nodulocystic 5 
BCe nodulocystic 5 
BCe nodulocystic 4 
BCC keratotic 1 
BCe adenoid 3 
BCC superficial 1 
BCe infiltrative 2 
Bee morpheaform 2 
Bee recurrent 3 
BSee' 1 
sec' 5 
• Sweat gland tumor. 
• Basal cell carcinoma. 
, Baso-squamous cell carcinoma. 
, Squamous cell carcinoma. 
lmmunostaining 92T4Cl+ 
Pattern' Cells! 
Type A + 
Type A + 
Type A + 
Type A + 
Type A + 
, Immunostaining patterns type A, B, and Care desaibed in detail in R esliits. 
lmmunostaining 92T4Cl+ Immunostaining 
Pattern Cells Pattern 
Type B +to+++ 
Type C 
Type C 
Type C 
TypeC 
Type C 
Type C 
f Estimate of the number of 92T4Cl containing positive cells in the tumor extracellular matrix; + (few) to +++ (abundant) . 
I Qualitative value for the quantity of extracellular 92T4CI present in the tumor extracellular matrix, + (minimal) to +++ (extenSive). 
92T4Cl+ Extracellular 
Cells 92T4CIs 
0 
0 
0 
+ ± 
0 
0 
0 
++ + 
++ + 
+++ +++ 
+++ ++ to+++ 
+++ +++ 
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Figure 3. Localization of 92T4Cl in normal human adult and fetal skin. 
a) 92T4CI-positive PMNs around the midportion (bulge region) of a hair 
follicle (H) in normal human adult trunk skin. Bar, 40 Jim. b) Fetal skin at 
13 weeks of gestation. 92T4Cl-positive mesenchymal cells ( ...... ) 
surrounding developing muscle (M) and sweat gland ducts (SG) in the 
deep dermis. Bar, 60 Jim. c) 92T4CI-containing mesenchymal ( ...... ) cells 
are present in the upper dermis of fetal skin at 24 weeks of gestation. E, 
epidermis, H, hair follicle. Bar, 60 Jim. 
basement membranes that is detectable by immunofluorescence mi-
croscopy. Whether in morpheaform BCCs the abundant deposition 
of 92T4CI is related to the alterations of the tumor-associated base-
ment membrane will require further study. The correlation be-
tween deposition of 92T4CI in the ECM and the aggressive behav-
ior of a tumor does suggest that the presence of extracellular enzyme 
plays a role in the pathogenesis of the tumor. We did not find a 
significant number of 92T4CI-containing cells or extracellular dep-
osition of this enzyme in fetal human skin; moreover, single or 
small clusters of 92T4CI-positive cells in fetal skin do not contain 
leukocyte antigens, so it seems unlikely that 92T4CI-bearing PMN 
invasion of tumors and deposition of the enzyme in the ECM repre-
sents a kind of onco-fetal recapitulation. In addition, 92T4CI-posi-
tive cells in fetal skin showed no direct correlation with developing 
hair follicles and does not appear to playa major role in appende-
geal development. The relationship between the accumulation of 
92T4CI-positive cells in skin tumors and the presence of 92T4Cl 
staining of cells near the midportion (bulge region) [17] of some 
normal adult hair follicles remains to be elucidated. Because in both 
cases 92T4CI-positive cells are PMN leukocytes, it is possible that 
the process observed in tumors has its counterpart in the normal 
physiology of the adult hair follicle. 
Finally, the localization of 92T4CI within PMNs in human skin 
tumors is in line with some recent findings on the cellular basis of 
protease expression in malignancy. It has been reported by Gran-
dahl-Hansen et al [22] that urokinase-type plasminogen activator in 
adenocarcinomas of human colon is also localized in the ECM but 
not in tumor cells. Similar results were obtained by Basset et al [8] 
when expression of a newly cloned metalloproteinase, stromelysin-
3, was found in ECM cells of human breast tumors by in situ hybrid-
ization. Also, interstitial collagenase has been localized in BCCs to 
the ECM and was not found in the tumor cells [23-26]. Thus, 
several different proteolytic enzymes in a number of different kinds 
of human neoplasms are provided by ECM cells but not by the 
tumor cells themselves, suggesting that this type of tumor-ECM 
interaction has general significance. 
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